Irreversible enzyme inhibitors. CLVII. Effect of bridge modification on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosultonyl-benzamidomethyl) phenozymethyl]pyrimidine. I.
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002473:Cell Wall / Q000187:drug effects; D005493:Folic Acid Antagonists; D066298:In Vitro Techniques; D007939:Leukemia L1210 / Q000201:enzymology; D008099:Liver / Q000201:enzymology; D051379:Mice; D011743:Pyrimidines / Q000138:chemical synthesis / Q000494:pharmacology*
D005493:Folic Acid Antagonists; D011743:Pyrimidines